212 related articles for article (PubMed ID: 29501865)
21. Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.
Thiel T; Ryk C; Chatzakos V; Hallén Grufman K; Bavand-Chobot N; Flygare J; Wiklund NP; de Verdier PJ
Cancer Lett; 2014 Jun; 348(1-2):119-25. PubMed ID: 24657658
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer.
Coulter JA; Page NL; Worthington J; Robson T; Hirst DG; McCarthy HO
J Gene Med; 2010 Sep; 12(9):755-65. PubMed ID: 20821746
[TBL] [Abstract][Full Text] [Related]
23. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines.
Huguenin S; Vacherot F; Fleury-Feith J; Riffaud JP; Chopin DK; Bolla M; Jaurand MC
Cancer Lett; 2005 Feb; 218(2):163-70. PubMed ID: 15670893
[TBL] [Abstract][Full Text] [Related]
25. A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study.
Rapozzi V; Varchi G; Della Pietra E; Ferroni C; Xodo LE
Invest New Drugs; 2017 Feb; 35(1):115-123. PubMed ID: 27726093
[TBL] [Abstract][Full Text] [Related]
26. NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.
Scicinski J; Oronsky B; Ning S; Knox S; Peehl D; Kim MM; Langecker P; Fanger G
Redox Biol; 2015 Dec; 6():1-8. PubMed ID: 26164533
[TBL] [Abstract][Full Text] [Related]
27. Changes in end products of nitric oxide in urine and induction of nitric oxide synthase expression in urinary bladder during intravesical instillations of IFN-alpha2b.
Mitropoulos D; Deliconstantinos G; Adamakis I; Zervas A; Karakaidos P; Gorgoulis VG
J Interferon Cytokine Res; 2004 Oct; 24(10):621-6. PubMed ID: 15626159
[TBL] [Abstract][Full Text] [Related]
28. [Advances in the study of nitric oxide-donating drugs].
Zhang YH; Peng SX
Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis.
Burke AJ; Garrido P; Johnson C; Sullivan FJ; Glynn SA
Antioxid Redox Signal; 2017 Jun; 26(18):1078-1090. PubMed ID: 28326819
[TBL] [Abstract][Full Text] [Related]
30. Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors.
Fernandez AP; Serrano J; Amorim MA; Pozo-Rodrigalvarez A; Martinez-Murillo R
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):820-33. PubMed ID: 21999731
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide in patients with transitional bladder cancer.
Eiján AM; Piccardo I; Riveros MD; Sandes EO; Porcella H; Jasnis MA; Sacerdote De Lustig E; Malagrino H; Pasik L; Casabé AR
J Surg Oncol; 2002 Dec; 81(4):203-8. PubMed ID: 12451625
[TBL] [Abstract][Full Text] [Related]
32. Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model.
Bhowmick R; Girotti AW
Cancer Lett; 2014 Feb; 343(1):115-22. PubMed ID: 24080338
[TBL] [Abstract][Full Text] [Related]
33. Human renal epithelial cells express iNOS in response to cytokines but not bacteria.
Poljakovic M; Karpman D; Svanborg C; Persson K
Kidney Int; 2002 Feb; 61(2):444-55. PubMed ID: 11849384
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.
Cronauer MV; Ince Y; Engers R; Rinnab L; Weidemann W; Suschek CV; Burchardt M; Kleinert H; Wiedenmann J; Sies H; Ackermann R; Kröncke KD
Oncogene; 2007 Mar; 26(13):1875-84. PubMed ID: 16983333
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis.
Lin Z; Chen S; Ye C; Zhu S
Urol Res; 2003 Aug; 31(4):232-5. PubMed ID: 12937869
[TBL] [Abstract][Full Text] [Related]
36. [Nitric oxide and anti-protozoan chemotherapy].
Gradoni L; Ascenzi P
Parassitologia; 2004 Jun; 46(1-2):101-3. PubMed ID: 15305696
[TBL] [Abstract][Full Text] [Related]
37. [Prostate-bladder rhabdomyosarcoma: therapeutic approaches].
Vesga Molina F; Albisu Tristan A; Blasco de Villalonga M; Llarena Ibarguren R; Pertusa Peña C
Arch Esp Urol; 1994 Dec; 47(10):985-9. PubMed ID: 7864680
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.
Kielbik M; Szulc-Kielbik I; Nowak M; Sulowska Z; Klink M
Toxicol In Vitro; 2016 Oct; 36():26-37. PubMed ID: 27427240
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice.
Cao G; Su J; Lu W; Zhang F; Zhao G; Marteralli D; Dong Z
Cancer Gene Ther; 2001 Jul; 8(7):497-505. PubMed ID: 11498771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
